0000899243-19-002466.txt : 20190204
0000899243-19-002466.hdr.sgml : 20190204
20190204164627
ACCESSION NUMBER: 0000899243-19-002466
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190204
DATE AS OF CHANGE: 20190204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gross Paul Edward
CENTRAL INDEX KEY: 0001766329
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 19564528
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY, SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-02-01
0
0001466301
Clovis Oncology, Inc.
CLVS
0001766329
Gross Paul Edward
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2345
D
Stock Option (right to buy)
22.99
2026-01-25
Common Stock
60000
D
Stock Option (right to buy)
68.31
2027-03-27
Common Stock
15000
D
Stock Option (right to buy)
58.43
2028-03-01
Common Stock
9000
D
Restricted Stock Units
2027-03-27
Common Stock
4219
D
Restricted Stock Units
2028-03-01
Common Stock
9000
D
The option vested as to 25% of the shares on January 25, 2017, and the remainder vests in substantially equal installments over the 36 months immediately following such date.
The option vested as to 25% of the shares on March 1, 2018, and the remainder vests in substantially equal installments over the 36 months immediately following such date.
The option vests as to 25% of the shares on March 1, 2019, and the remainder vests in substantially equal installments over the 36 months immediately following such date.
The Restricted Stock Units vested as to 25% of the units on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Each Restricted Stock Unit represents the right to receive one share of Common Stock.
The Restricted Stock Units vest as to 25% of the units on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Executive Vice President, General Counsel and Chief Compliance Officer
/s/ Paul Gross
2019-02-01